ClinicalTrialsFinder
RecruitingNot ApplicableNCT04441151

Evaluation of the Effect of Pulmonary Rehabilitation on Patients With High Flow Oxygen Therapy

Sponsor

Chinese PLA General Hospital

Enrollment

70 participants

Start Date

Mar 20, 2025

Study Type

INTERVENTIONAL

Conditions

Pulmonary Disease

Summary

Evaluation of the effect of pulmonary rehabilitation on patients with high flow oxygen therapy

Eligibility

Min Age: 18 YearsMax Age: 100 Years

Inclusion Criteria10

  • The age is ≥ 18 years old;
  • the hemodynamics is stable;
  • < heart rate < 120 beats / min ;
  • < systolic blood pressure < 200mmHg ;
  • < mean arterial pressure < 120mmHg;
  • do not increase the dose of pressor drugs for at least 2 hours;
  • intracranial pressure is stable and there are no seizures within 24 hours;
  • the respiratory state is stable;
  • the patient's finger pulse oxygen saturation ≥ 88%;
  • < respiratory frequency < 35 beats / min.

Exclusion Criteria4

  • Pregnancy;
  • acute cardio-cerebrovascular events;
  • spinal or limb fractures;
  • active bleeding.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPulmonary rehabilitation therapy

Comprehensive interventions based on comprehensive evaluation and customization of patients, including, but not limited to, exercise training, education and behavioral changes, aimed at improving the physiological and psychological status of patients with chronic respiratory diseases, and urge patients to adhere to health promotion activities for a long time.

Locations(1)

Chinese PLAGH Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT04441151

Related Trials

Study of Lung Proteins in Patients With Pneumonia

NCT000779091 location

Merck IIT: RRP Pembro and Lenvatinib

NCT046456021 location

Natural History Study of Biomarkers in Pulmonary Arterial Hypertension

NCT017300921 location

Functional Lung Avoidance SPECT-guided Radiation Therapy of Lung Cancer

NCT046768282 locations

Cooperative Assessment of Late Effects for SCD Curative Therapies

NCT051539675 locations